PT  - JOURNAL ARTICLE
AU  - Anja Jochmann
AU  - Daniel Trachsel
AU  - Jürg Hammer
TI  - Inflammatory bowel disease and the lung in paediatric patients
AID  - 10.1183/20734735.0269-2020
DP  - 2021 Mar 01
TA  - Breathe
PG  - 200269
VI  - 17
IP  - 1
4099  - http://breathe.ersjournals.com/content/17/1/200269.short
4100  - http://breathe.ersjournals.com/content/17/1/200269.full
SO  - Breathe2021 Mar 01; 17
AB  - The prevalence of inflammatory bowel disease (IBD) has increased over the past 20 years. Pulmonary involvement in paediatric IBD is rare but may be missed since the spectrum of symptoms is broad and mimics other diseases. The most important differential diagnoses of pulmonary manifestations of IBD are infections and therapy-related side-effects. There is no gold standard to diagnose respiratory manifestations in children with IBD. Diagnostic tests should be chosen according to history and clinical presentation. Treatment of respiratory manifestations of IBD includes inhaled or oral corticosteroids and initiation or step-up of immunomodulatory IBD therapies.Pulmonary involvement in paediatric IBD is rare but may be underdiagnosed. The spectrum of symptoms is broad and mimics other diseases. The differentiation between IBD-related and drug-induced pulmonary manifestation can be challenging. https://bit.ly/3uZBvpA